Molecular Medicine

Special Issues

Following special issues within this section are currently open for submissions:

• Novel Insights on Cancer Stem Cells (Deadline: 30 September 2023)
• Molecular Research on Thrombotic Microangiopathy and Thrombotic Complications (Deadline: 30 September 2023)
• Pathogenesis and Potential Treatments of Neurointestinal Diseases (Deadline: 30 September 2023)
• α-Synuclein Amyloids & Parkinson’s Disease: On Growth, Spread, and Neurodegeneration 2.0 (Deadline: 30 September 2023)
• Placental-Related Disorders of Pregnancy (Deadline: 30 September 2023)
• The Role of Tumor Microenvironment in the Pathogenesis and Progression of Hematological Maglignancies (Deadline: 30 September 2023)
• Role of Mesenchymal Cells in Wound Healing and Fibrosis (Deadline: 30 September 2023)
• New Biomarkers of Cardiometabolic and Inflammatory Disorders: A Themed Issue in Honor of Professor Robin Pieter Frank Dullaart (Deadline: 30 September 2023)
• Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease II (Deadline: 15 October 2023)
• Molecular Mechanisms of Kidney Injury and Repair II (Deadline: 15 October 2023)
• Research Advances in the Pathogenesis, Diagnosis and Treatment of Diabetic Kidney Disease (Deadline: 15 October 2023)
• Epigenetics in Parathyroid Tumors (Deadline: 30 October 2023)
• Advances in Oxygen Therapy with a Special Focus on Immunomodulation and Infection (Deadline: 30 October 2023)
• Role of CaM Kinase II in the Neuropsychiatry Disorders and Drug Addiction (Deadline: 30 October 2023)
• Molecular Mechanisms of Retinal Degenerative Conditions (Deadline: 30 October 2023)
• Advances in the Role of Mitochondria in Regulated Cell Death Dysfunctions Associated with Human Pathologies (Deadline: 30 October 2023)
• PPARs as Key Regulators in Different Diseases (Deadline: 31 October 2023)
• Muscle Atrophy and Hypertrophy: Mechanisms and Potential Therapies (Deadline: 31 October 2023)
• Potential Therapeutic Value of Thrombospondin-1: A Multi-Factorial Mediator in Cardiovascular/Endothelial Pathologies (Deadline: 31 October 2023)
• Future Perspective of Gene Therapy in Metabolic and Neuromuscular Diseases (Deadline: 31 October 2023)
• Stress, Aging and Metabolism (Deadline: 31 October 2023)
• Toxic and Essential Metals in Human Health and Disease 2022-2023 (Deadline: 31 October 2023)
• Exploration of Epigenetic Concepts That Impact Cancer Immune Infiltration and Immunotherapy (Deadline: 31 October 2023)
• Colorectal Cancer: Molecular Mechanism and Potential Biomarkers (Deadline: 31 October 2023)
• Linking Neurotoxicity Mechanisms with Neurological and Psychiatric Disorders (Deadline: 31 October 2023)
• Advances in Biomarkers for Neurodegenerative Diseases (Deadline: 31 October 2023)
• Plasticity in the Visual and Other Systems: Energy Metabolism, Neurochemical and Physiological Bases—Honorary Special Issue Commemorating the Work of Prof. Margaret Wong-Riley (Deadline: 31 October 2023)
• RNA-Binding Proteins and Non-coding RNAs in Cancer Therapeutic Resistance (Deadline: 6 November 2023)
• New Insights into Cardiovascular Immunology (Deadline: 15 November 2023)
• Human Gut Microbiome and Diet in Health and Diseases (Deadline: 15 November 2023)
• Regulation of Notch Signaling Pathway and Its Relation to Diseases (Deadline: 24 November 2023)
• Targeting Neuroinflammation and Insulin Resistance for a Healthy Brain: Prevention and Treatment of Neurological and Psychiatric Disorders (Deadline: 30 November 2023)
• Amyloid-Beta (Aβ) Production/Clearance Balance and Aβ Neurotoxicity in Alzheimer’s Disease: From Mechanisms to Therapy (Deadline: 30 November 2023)
• Novel Insights into Gamma Delta T Cells (γδ T Cells): Receptors, Molecular Targets, and Therapeutic Potentials (Deadline: 30 November 2023)
• Molecular Mechanisms and Pharmacological Target of Neuroprotection (Deadline: 30 November 2023)
• Advanced Nanotechnology for Health and Diseases (Deadline: 30 November 2023)
• Pathogenesis and Drug Development for Non-communicable Inflammatory Skin Diseases II (Deadline: 30 November 2023)
• Eosinophils in Allergy and Related Diseases—Selected Papers from “The Workshop on Eosinophils in Allergy and Related Diseases 2022” (Deadline: 30 November 2023)
• Molecular Mechanisms of Solid Cancers Chemoresistance: Emerging Biomarkers and Promising Therapies (Deadline: 30 November 2023)
• Lysosomal Diseases: From Molecular Features to Precision Medicine (Deadline: 30 November 2023)
• Targeting Sodium Channels and Pumps for Cancer Therapy (Deadline: 30 November 2023)
• Advances in the Molecular Mechanisms of Inflammatory Arthritis and Inflammation-Related Bone Changes (Deadline: 1 December 2023)
• Molecular Research on Airway Diseases (Deadline: 1 December 2023)
• Molecular Research in Uterine Physiology and Pathology (Deadline: 15 December 2023)
• Aptamer Therapeutics in Cancers: New Advances and Future Trends (Deadline: 15 December 2023)
• Molecular Pathology, Diagnostics and Therapeutics of Retinal Diseases (Deadline: 15 December 2023)
• Pathological Roles of LRRK2 (Deadline: 15 December 2023)
• Animal Models: Exploring the Biological Bases and New Experimental Therapies for Neurodevelopmental Disorders (Deadline: 20 December 2023)
• Brain-Derived Neurotrophic Factor in Health and Diseases (Deadline: 20 December 2023)
• State of the Art in Antiviral Therapy and Viral Diseases Diagnosis: An Update to 2022-2023 (Deadline: 23 December 2023)
• Dietary Phytochemicals - Mediated Cellular Signalling, Epigenetics/Epigenomics and Cancer Chemoprevention (Deadline: 30 December 2023)
• Drug Repurposing in Cancer Therapies (Deadline: 30 December 2023)
• Aging and Aging-Associated Diseases: From Molecular Mechanisms to Therapies Strategies 2.0 (Deadline: 30 December 2023)
• Molecular and Biochemical Mechanisms of Age-Related Macular Degeneration, Neuroophthalmological Diseases and Uveitis (Deadline: 30 December 2023)
• Retinal Diseases: Molecular Updates and Perspectives (Deadline: 31 December 2023)
• Chemopreventive and Therapeutic Potential of Phytochemicals and Their Analogs against Cancer (Deadline: 31 December 2023)
• Advances in Brain Development and Disease (Deadline: 31 December 2023)
• New Advances in Drug Repurposing for Oncology (Deadline: 31 December 2023)
• Advances in Melanoma Targeted Therapy (Deadline: 31 December 2023)
• The Role of Epithelial Cells in Airway Diseases (Deadline: 31 December 2023)
• PARPs in Cell Death and PARP Inhibitors in Cancers (Deadline: 31 December 2023)
• H₂S, Polysulfides, and Enzymes: Physiological and Pathological Aspects 2.0 (Deadline: 31 December 2023)
• Drug Delivery Nanosystems for Biomedical Applications (Deadline: 31 December 2023)
• Engineered TCR and CAR Cells for Immunotherapy of Solid Tumors (Deadline: 31 December 2023)
• Fibrodysplasia Ossificans Progressiva (FOP): From Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 December 2023)
• Dysregulation of Calcium Signaling in Pathological Processes (Deadline: 31 December 2023)
• Melatonin in Health and Disease (Deadline: 31 December 2023)
• Emerging Molecular Targets in Sjogren’s Syndrome 2.0 (Deadline: 31 December 2023)
• Digital Pathology 2.0 (Deadline: 31 December 2023)
• Matrix Metalloproteinases in Health and Disease 4.0 (Deadline: 31 December 2023)
• Esophageal Diseases: Molecular Basis and Therapeutic (Deadline: 31 December 2023)
• Nutrition, Metabolism, and Obesity: Novel Strategies and Molecular Mechanisms—Future Perspectives (Deadline: 31 December 2023)
• Molecular Basis of Autoimmune Diseases (Deadline: 31 December 2023)
• Polyamines in the Central Nervous System: Neurons, Glial Cells and Diseases 2.0 (Deadline: 8 January 2024)
• Learn from Machine Learning: The Identification of Biomarkers and Therapeutic Targets in Neurodegeneration (Deadline: 15 January 2024)
• Sex Differences in Biomedical Research (Deadline: 15 January 2024)
• Inositol Phosphates in Health and Disease Volume II (Deadline: 20 January 2024)
• Aryl Hydrocarbon Receptor in Hepatic and Metabolic Diseases (Deadline: 31 January 2024)
• Non-communicable Diseases：Molecular Updates and Perspectives (Deadline: 31 January 2024)
• Role of the Endogenous Cannabinoid System in Neuroinflammation and Its Therapeutic Potential in Neuropsychiatry (Deadline: 31 January 2024)
• State of the Art and Perspectives in Antimicrobial Peptides (Deadline: 31 January 2024)
• Tissue Calcification in Normal and Pathological Environments (Deadline: 31 January 2024)
• Lipids in Health and Diseases (Deadline: 31 January 2024)
• Innovative Immunology: A Themed Issue Dedicated to Professor Moriya Tsuji (Deadline: 31 January 2024)
• Tandem Repeats in Neuromuscular Diseases: Recent Developments in Translational Research (Deadline: 15 February 2024)
• Role of Connexins in Hereditary Diseases (Deadline: 15 February 2024)
• Novel Insights into Molecular Mechanisms of Endometrial Diseases (Deadline: 15 February 2024)
• Insights of Innate Immunology into Inflammation and Infections (Deadline: 29 February 2024)
• AnxA1 and Resolution Pathways in Inflammatory Based Disease 2.0 (Deadline: 29 February 2024)
• Recent Advances in Liposome-Based Drug Delivery (Deadline: 29 February 2024)
• Molecular Targets for Breast Cancer Therapy (Deadline: 29 February 2024)
• New Insights into the Regulation of Inflammation: Mechanisms, Mediators and Therapeutic Targeting (Deadline: 29 February 2024)
• Targets and Treatment Approaches for End-Stage Liver Diseases (Deadline: 29 February 2024)
• Viral Drug Targets and Discovery of Antiviral Agents (Deadline: 5 March 2024)
• Lymphangiogenesis in Health and Disease (Deadline: 10 March 2024)
• Tuberculosis: Immunopathogenesis and Therapeutic Strategies (Deadline: 15 March 2024)
• From the Past to the Present: Unveiling the Role of Biomolecules in Clinical History (Deadline: 15 March 2024)
• Molecular Mechanisms of Alpha-Synuclein in Parkinson's Disease and Other Synucleinopathies (Deadline: 30 March 2024)
• Viral Respiratory Infection including COVID-19: From Molecular Mechanisms to Therapies Strategies (Deadline: 31 March 2024)
• Novel Insights into Autoimmune/Autoinflammatory Skin Diseases (Deadline: 31 March 2024)
• New Insights into Mechanisms and Therapeutics for Cardiovascular Disorders (Deadline: 31 March 2024)
• Ocular Damage and Wound Healing: From Mechanisms Exploration to Treatment (Deadline: 31 March 2024)
• Applications of Mesenchymal Stem/Stromal Cells in Immuno-Oncology Therapy and The Priming Ways to Boost Their Functions (Deadline: 31 March 2024)
• Molecular Interventions in Ocular Disorders (Deadline: 31 March 2024)
• Novel Molecules for Cancer Treatment 2.0 (Deadline: 31 March 2024)
• The Molecular Mechanisms Underlying the Pathogenic Activity of γ-Secretase in Alzheimer's Disease (Deadline: 31 March 2024)
• The Role of Arginine and Arginine Metabolites in Cerebro- and Cardiovascular Disease Targeted Therapy (Deadline: 31 March 2024)
• Molecular Pathology of Amyotrophic Lateral Sclerosis (Deadline: 30 April 2024)
• Ion Channel Signaling in Cancer (Deadline: 30 April 2024)
• The Role of Microglia in Aging and Neurodegenerative Disease (Deadline: 30 April 2024)
• Biomolecules in Development and Diseases of Urogenital System II (Deadline: 30 April 2024)
• The Role of Glial Cells in Neuroinflammation, Neurodegeneration, and Neuroimmunomodulation (Deadline: 30 April 2024)
• Epigenetics of Pulmonary Diseases (Deadline: 30 June 2024)
• Signal Transduction to Transcription Factors in Health and Disease—Honorary Special Issue Commemorating the Work of Prof. Athanasios G. Papavassiliou (Deadline: 30 June 2024)
• Recent Trends in Kidney and Cardiovascular Diseases (Deadline: 31 July 2024)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Drug-Phototherapy
• Emerging Targets and Tissue Engineering Strategies for Repair and Regeneration
• Feature Papers in Section Molecular Medicine
• Metabolomics and Integrated Multi-Omics in Health and Disease
• Multi-Organ Alcohol-Related Damage: Mechanisms and Treatment
• Natural and Synthetic Compounds in Neurodegenerative Disorders
• Recent Advances in Cancer Immunotherapy
• Recent Advances in Pancreatic Cancer